off

Sonia Guil, from the Josep Carreras Leukemia Research Institute, and Lourdes Farré, from the Bellvitge Biomedical Research Institute (Idibell), have described how in a region … Read more

“There is no shortage of metrotexate in the National Cancer Institute“said the Dr. Abelardo Meneses, who runs this center. During a press conference at the … Read more

Head and neck cancer produces 350,000 deaths each year in the world and 85 percent of cases are due to tobacco use, as reported by … Read more

Researchers of the Faculty of Medicine of the University of Virginia (United States) have identified “We have discovered a new non-coding RNA that may be … Read more

The US drug agency (FDA) has approved darolutamide, a non-steroidal androgen receptor antagonist, under the trade name of Nubeqa. The FDA-approved indication is the treatment … Read more

Spanish researchers from Integral Cancer Center Clara Campal HM CIOCC They have defined for the first time a series of molecular markers that identify those … Read more

Scientists at the Georgetown University Medical Center (United States) have discovered a mechanism that could explain why some cancers do not respond to a widely … Read more

Researchers at the Josep Carreras Leukemia Research Institute have described an epigenetic lesion that causes in breast cancer the “aberrant activity” of a hundred genes … Read more

Researchers of Molecular Therapy Research Group of the cancer of the Hospital del Mar Institute of Medical Research (IMIM) and doctors of the Hospital del … Read more

The European Commission has approved the combination of Tecentriq (atezolizumab) plus chemotherapy (Abraxane) for the treatment of patients with locally unresectable or metastatic advanced breast … Read more